A Double-Blind, Randomized, Crossover Trial of CSII Reservoir In-use Comparing Insulin Lispro Formulation to Insulin Aspart in Patients with Type 1 Diabetes Mellitus

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-018664-16

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

1. Day 6 of 6 days (6D) of pump reservoir in-use of Humalog is noninferior to Day 6 of 6D of pump reservoir in-use of insulin aspart with regards to 7-point daily mean SMBG (with a margin of 0.6 mmol/L) 2. Day 6 of 6D of pump reservoir in-use of Humalog is superior to Day 6 of 6D of pump reservoir in-use of insulin apart with regards to 7-point daily mean SMBG


Critère d'inclusion

  • Type 1 Diabetes